Simplex Trading’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-50
| Closed | -$23K | – | 8281 |
|
|
2019
Q1 | $23K | Buy |
50
+17
| +52% | +$80 | ﹤0.01% | 5635 |
|
|
2018
Q4 | $11K | Sell |
33
-49
| -60% | -$341 | ﹤0.01% | 5820 |
|
|
2018
Q3 | $82K | Sell |
82
-100
| -55% | -$798 | ﹤0.01% | 4646 |
|
|
2018
Q2 | $131K | Buy |
182
+75
| +70% | +$523 | ﹤0.01% | 3969 |
|
|
2018
Q1 | $12K | Sell |
107
-20
| -16% | -$165 | ﹤0.01% | 3916 |
|
|
2017
Q4 | $41K | Buy |
127
+69
| +119% | +$452 | ﹤0.01% | 2644 |
|
|
2017
Q3 | $2K | Sell |
58
-211
| -78% | -$2.18K | ﹤0.01% | 5273 |
|
|
2017
Q2 | $52K | Sell |
269
-167
| -38% | -$1.98K | ﹤0.01% | 2367 |
|
|
2017
Q1 | $50K | Sell |
436
-14
| -3% | -$149 | ﹤0.01% | 2377 |
|
|
2016
Q4 | $7K | Buy |
450
+75
| +20% | +$847 | ﹤0.01% | 4127 |
|
|
2016
Q3 | $7K | Buy |
+375
| New | +$5.7K | ﹤0.01% | 4031 |
|
|
2016
Q2 | – | Sell |
-358
| Closed | -$30K | – | 6803 |
|
|
2016
Q1 | $30K | Buy |
358
+186
| +108% | +$3.53K | ﹤0.01% | 2442 |
|
|
2015
Q4 | $88K | Buy |
172
+150
| +682% | +$4.16K | 0.01% | 1463 |
|
|
2015
Q3 | $7K | Sell |
22
-68
| -76% | -$2.5K | ﹤0.01% | 3779 |
|
|
2015
Q2 | $95K | Sell |
90
-26
| -22% | -$810 | 0.01% | 1235 |
|
|
2015
Q1 | $78K | Sell |
116
-18
| -13% | -$476 | 0.01% | 1256 |
|
|
2014
Q4 | $40K | Buy |
+134
| New | +$2.65K | ﹤0.01% | 1534 |
|
Simplex Trading's INSY Position: Q1 2019 in Review
Simplex Trading sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 1,075 shares — an estimated $5.09K sold.
Simplex Trading first reported a position in INSY in Q1 2016 and held it in 11 quarters. The position peaked at $554K in Q2 2016. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.
- Simplex Trading reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
- Simplex Trading sold 1,075 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $5.09K.
- Simplex Trading first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 11 quarters.
- Simplex Trading's Insys Therapeutics, Inc. position peaked at $554K in Q2 2016.
- 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.
Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.